Sponsor:
Zenalux Biomedical, Inc.
Code:
NCT02943044
Conditions
Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 24 - 70+
Healthy Volunteers: Not accepted
Interventions
No intervention, this is an observational study
Brief summary:
Conditions
Squamous Cell Carcinoma
Study ID
NCT02943044
Start date
Dec, 2016
Status verified date
Mar, 2017
Completion date
Dec, 2017
Anticipated
Primary completion date
Dec, 2017
Anticipated
Eligibility Criteria
Sex: All
Age: 24 - 70+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Interventions
No intervention, this is an observational study
Primary outcome measure
Central contacts
Locations
Duke University Medical Center
Recruiting
Durham, North Carolina, United States, 27705
Contacts
Principal Investigator:
Walter Lee, MD
Sponsor
Zenalux Biomedical, Inc.
Last update posted
Mar 3, 2017
Last verified
Mar, 2017
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Zenalux Biomedical, Inc. on 2017-03-03.